Showing 1–5 of 5 results
-
Amendments and Corrections | | Open
-
Amendments and Corrections |
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
- Jennifer N. Brudno
- , Norris Lam
- , Danielle Vanasse
- , Yueh-wei Shen
- , Jeremy J. Rose
- , John Rossi
- , Allen Xue
- , Adrian Bot
- , Nathalie Scholler
- , Lekha Mikkilineni
- , Mark Roschewski
- , Robert Dean
- , Raul Cachau
- , Philippe Youkharibache
- , Rashmika Patel
- , Brenna Hansen
- , David F. Stroncek
- , Steven A. Rosenberg
- , Ronald E. Gress
- & James N. Kochenderfer
-
Research | | Open
-
Research | | Open
-
Research |
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
- Jennifer N. Brudno
- , Norris Lam
- , Danielle Vanasse
- , Yueh-wei Shen
- , Jeremy J. Rose
- , John Rossi
- , Allen Xue
- , Adrian Bot
- , Nathalie Scholler
- , Lekha Mikkilineni
- , Mark Roschewski
- , Robert Dean
- , Raul Cachau
- , Philippe Youkharibache
- , Rashmika Patel
- , Brenna Hansen
- , David F. Stroncek
- , Steven A. Rosenberg
- , Ronald E. Gress
- & James N. Kochenderfer